WestEnd Advisors, LLC holds a focused book of 408 stocks worth $4.5B as of Q2 2026 (disclosed Jul 22, 2026, a ~22-day 13F lag). This quarter they opened Ishares US Transportation Et and trimmed Vanguard Ftse All-World Ex-U. Their largest long position is SS Technology Select Sector at 14% of the equity book. Cloning the disclosed picks since 2013 would be +281% (+11.0%/yr). That is a simulation of the disclosed long book, not audited returns.
The reported book (valued from quarter-end) returned +293.2%, a 12.3-point gap that is the cost of the ~22-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning WestEnd Advisors, LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~22 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
16% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as WestEnd Advisors, LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 80 / 80 | $548.7B |
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $386.1B |
| ROYAL BANK OF CANADA | 80 / 80 | $158.4B |
| WELLS FARGO & COMPANY/MN | 80 / 80 | $154.9B |
| UBS Group AG | 80 / 80 | $146.6B |
| ENVESTNET ASSET MANAGEMENT INC | 80 / 80 | $82.8B |
| LPL Financial LLC | 80 / 80 | $76.3B |
| Cetera Investment Advisers | 80 / 80 | $19.2B |
Ranked by how many of WestEnd Advisors, LLC's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Select Sector SPDR TR Sbi Int- Common Stock | $640.2M | 3.36M | 14.3% | ▲+4.2% Added · +137K sh | |
| 2 | Select Sector SPDR TR Sbi Int- Common Stock | $464.4M | 8.66M | 10.4% | ▲+12% Added · +898K sh | |
| 3 | Ishares TR Core Msci Euro Common Stock | $364.0M | 4.84M | 8.1% | ▲+26% Added · +998K sh | |
| 4 | Select Sector SPDR TR Common Stock | $309.4M | 1.95M | 6.9% | ▲+3.8% Added · +72K sh | |
| 5 | Vanguard Intl Equity Index F A Common Stock | $301.1M | 3.60M | 6.7% | ▼−5.3% Reduced · −201K sh | |
| 6 | Select Sector SPDR TR Communic Common Stock | $236.0M | 2.20M | 5.3% | ▼−22% Reduced · −636K sh | |
| 7 | Vanguard Scottsdale FDS SHRT-T Common Stock | $153.6M | 1.94M | 3.4% | ▲+33% Added · +486K sh | |
| 8 | Ishares TR 20 Yr TRS BD Common Stock | $149.3M | 1.73M | 3.3% | ▲+83% Added · +784K sh | |
| 9 | Ishares TR Lehman 3-7 Yr Common Stock | $129.2M | 1.10M | 2.9% | ▼−8.8% Reduced · −106K sh | |
| 10 | Ishares TR Sandp Smlcap 600 Common Stock | $125.7M | 847.2K | 2.8% | ▼−9.6% Reduced · −90K sh | |
| 11 | Ishares TR Ishares Biotech Common Stock | $124.7M | 655.9K | 2.8% | ▲+1.2% Added · +8K sh | |
| 12 | Select Sector SPDR TR Sbi Cons Common Stock | $120.3M | 1.03M | 2.7% | ▲+9.6% Added · +90K sh | |
| 13 | Ishares TR US Trsprtion Common Stock | $120.0M | 1.38M | 2.7% | ▲New New position | |
| 14 | Select Sector SPDR TR Sbi Int- Common Stock | $117.5M | 2.59M | 2.6% | ▲+7.4% Added · +178K sh | |
| 15 | Ishares TR GLDM Sachs Tec Common Stock | $116.9M | 714.9K | 2.6% | ▼−14% Reduced · −121K sh | |
| 16 | Select Sector SPDR TR Sbi Mate Common Stock | $113.3M | 2.23M | 2.5% | ▲4k× Added · +2.2M sh | |
| 17 | Ishares TR 7-10 Yr TRS BD Common Stock | $80.6M | 852.6K | 1.8% | ▲+9.4% Added · +73K sh | |
| 18 | Vanguard Intl Equity Index F P Common Stock | $60.3M | 521.3K | 1.3% | ▼−9.3% Reduced · −53K sh | |
| 19 | Nvidia Corp Common Stock | $58.4M | 291.9K | 1.3% | ▼−11% Reduced · −36K sh | |
| 20 | Texas Instrs Inc Common Stock | $53.8M | 180.4K | 1.2% | ▼−10% Reduced · −21K sh | |
| 21 | Apple Inc Com Common Stock | $48.7M | 168.3K | 1.1% | ▼−9.8% Reduced · −18K sh | |
| 22 | Alphabet Inc Cap STK CL A Common Stock | $44.6M | 124.7K | 1.0% | ▼−10% Reduced · −14K sh | |
| 23 | Amazon Com Inc Common Stock | $41.7M | 174.8K | 0.9% | ▼−10% Reduced · −20K sh | |
| 24 | United Parcel Service Inc Common Stock | $40.8M | 379.6K | 0.9% | ▲New New position | |
| 25 | J P Morgan Chase And Co Common Stock | $39.7M | 121.4K | 0.9% | ▼−11% Reduced · −15K sh | |
| 26 | Chubb Limited Com Common Stock | $37.8M | 110.9K | 0.8% | ▼−11% Reduced · −14K sh | |
| 27 | Microsoft Corp Common Stock | $36.7M | 98.3K | 0.8% | ▼−8.5% Reduced · −9K sh | |
| 28 | Mastercard Incorporated CL A Common Stock | $36.2M | 70.5K | 0.8% | ▼−11% Reduced · −9K sh | |
| 29 | Thermo Fisher Scientific Inc C Common Stock | $35.5M | 70.8K | 0.8% | ▼−14% Reduced · −12K sh | |
| 30 | TJX Cos Inc Common Stock | $34.2M | 225.6K | 0.8% | ▼−11% Reduced · −27K sh | |
| 31 | Meta Platforms Inc CL A Common Stock | $31.5M | 55.9K | 0.7% | ▼−15% Reduced · −10K sh | |
| 32 | Medtronic PLC SHS Common Stock | $30.0M | 382.9K | 0.7% | ▼−14% Reduced · −60K sh | |
| 33 | Pepsico Inc Common Stock | $29.7M | 219.1K | 0.7% | ▼−11% Reduced · −28K sh | |
| 34 | S And P Global Inc Common Stock | $27.5M | 67.4K | 0.6% | ▼−16% Reduced · −13K sh | |
| 35 | Salesforce Inc Com Common Stock | $26.9M | 171.5K | 0.6% | ▼−19% Reduced · −39K sh | |
| 36 | State STR SPDR SNP 500 ETF TR Common Stock | $22.6M | 30.2K | 0.5% | ▲+18% Added · +5K sh | |
| 37 | Qualcomm Inc Common Stock | $21.3M | 115.4K | 0.5% | ▼−11% Reduced · −15K sh | |
| 38 | T-Mobile US Inc Common Stock | $20.4M | 121.7K | 0.5% | ▼−12% Reduced · −16K sh | |
| 39 | Intuit Common Stock | $16.9M | 64.6K | 0.4% | ▼−21% Reduced · −17K sh | |
| 40 | Regeneron Pharmaceuticals Common Stock | $12.1M | 19.4K | 0.3% | ▼−24% Reduced · −6K sh | |
| 41 | Select Sector SPDR TR Sbi Cons Common Stock | $2.2M | 26.7K | 0.0% | ▼−99% Reduced · −2.8M sh | |
| 42 | Ishares Inc Emkts Asia Idx Common Stock | $1.8M | 15.1K | 0.0% | ▼−97% Reduced · −562K sh | |
| 43 | Ishares TR Msci Acwi Indx Common Stock | $1.5M | 9.7K | 0.0% | ▼−86% Reduced · −59K sh | |
| 44 | Ishares TR SNP GRWTH All Common Stock | $942K | 13.6K | 0.0% | ▼−83% Reduced · −67K sh | |
| 45 | Walmart Inc Common Stock | $821K | 7.2K | 0.0% | ▼−98% Reduced · −323K sh | |
| 46 | Ishares Core S&P 500 ETF Common Stock | $786K | 1.1K | 0.0% | ▲+275% Added · +770 sh | |
| 47 | Vanguard Scottsdale FDS Int-Te Common Stock | $644K | 7.8K | 0.0% | ▼−99% Reduced · −708K sh | |
| 48 | Ishares Russell 1000 ETF Common Stock | $428K | 1.0K | 0.0% | ▼−0.9% Reduced · −10 sh | |
| 49 | Global X FDS GLB X MLP Enrg I Common Stock | $189K | 2.6K | 0.0% | ▼−7.4% Reduced · −206 sh | |
| 50 | Ishares Inc Msci Tiw ETF New Common Stock | $174K | 1.6K | 0.0% | ▼−51% Reduced · −2K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1351731/holdings"
Use Arkolith to show WestEnd Advisors, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 22, 2026 | 408 | $4.5B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 22, 2026 | 391 | $4.1B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 27, 2026 | 390 | $4.3B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 22, 2025 | 390 | $4.3B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 23, 2025 | 367 | $4.0B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 25, 2025 | 362 | $3.8B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 28, 2025 | 341 | $3.9B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 25, 2024 | 399 | $4.1B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 29, 2024 | 367 | $3.9B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 | 355 | $3.9B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Jan 18, 2024 | 301 | $3.6B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Oct 19, 2023 | 301 | $3.3B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 21, 2023 | 42 | $3.4B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | Apr 28, 2023 | 312 | $3.2B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Jan 31, 2023 | 311 | $3.1B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Oct 27, 2022 | 323 | $3.0B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Jul 28, 2022 | 308 | $3.2B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | Apr 26, 2022 | 331 | $3.7B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Jan 14, 2022 | 387 | $3.7B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Oct 26, 2021 | 383 | $3.3B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Jul 15, 2021 | 379 | $3.1B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | Apr 27, 2021 | 54 | $2.5B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Jan 28, 2021 | 55 | $2.0B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Oct 22, 2020 | 55 | $1.7B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.